Download PDF
Thromb Haemost 1984; 52(02): 124-126
DOI: 10.1055/s-0038-1661154
Original Article
Schattauer GmbH Stuttgart

The Fast Inhibitor of Tissue Plasminogen Activator in Plasma During Pregnancy

B Wiman
The Department of Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden
,
G Csemiczky
*   The Department of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden
,
L Marsk
*   The Department of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden
,
H Robbe
*   The Department of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden
› Author Affiliations
Further Information

Publication History

Received 30 November 1983

Accepted 23 June 1984

Publication Date:
19 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The novel fast inhibitor to tissue plasminogen activator in plasma has been determined in 20 healthy non-pregnant women, 48 apparently healthy pregnant women and 136 women with risk pregnancies (preeclampsia, suspected fetal growth retardation, thrombosis or previous history of thrombosis, diabetes and others). In healthy fertile non-pregnant women, the inhibitor concentration was found to be 0.4 ± 0.7 U/ml. In pregnant women the concentration stayed at this level until week 10, but then an almost linear increase was found, reaching about 6.5 U/ml at week 40. In plasma samples from the patients with risk pregnancies many with deviating concentrations were found. Thus, in the last trimester a range of 0-24.0 U/ml was found in these patients, as compared to 4.0-6.4 U/ml in healthy pregnant women. The pathophysiological impact of this finding is at present unclear.

Keywords

Fibrinolysis - Plasminogen activator inhibition - Pregnancy - Risk pregnancy
 

  • References

  • 1 Chmielewska J, Rånby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436
    CrossrefPubMedGoogle Scholar
  • 2 Wiman B, Chmielewska J, Rånby M. Inactivation of tissue plasminogen activator in plasma: Demonstration of a complex with a new rapid inhibitor. J Biol Chem 1984; 259: 364-367
    PubMedGoogle Scholar
  • 3 Åstedt B, Isacson S, Nilsson IM. Fibrinolytic activity of veins during pregnancy. Acta Obstet Gynecol Scand 1970; 49: 171-173
    CrossrefPubMedGoogle Scholar
  • 4 Wiman B, Mellbring G, Rånby M. Plasminogen activator release during venous stasis and exercise as determined with a new specific assay. Clin Chim Acta 1983; 127: 279-288
    CrossrefPubMedGoogle Scholar
  • 5 Rånby M, Norrman B, Wallén P. A sensitive assay for tissue plasminogen activator. Thromb Res 1982; 27: 743-749
    CrossrefPubMedGoogle Scholar
  • 6 Wallén P, Pohl G, Bergsdorf N, Rånby M, Ny T, Jörnvall H. Purification and structural characterization of a melanoma cell plasminogen activator. Eur J Biochem 1983; 132: 681-686
    CrossrefPubMedGoogle Scholar
  • 7 Kruithof EK O, Ransijn A, Bachmann F. Inhibition of tissue plasminogen activator by human plasma. In: “Progress in Fibrinolysis”. Davidson JF, Bachmann F. (eds.) Churchill-Livingstone; Edinburgh: 1983. 6 365-369
    Google Scholar
  • 8 Verheijen JH, Chang GT G, Mullart E. Inhibition of extrinsic (tissue- type) plasminogen activator by human plasma: evidence for the occurrence of a fast acting inhibitor. Thromb Haemostas 1983; 50: 294 (Abstr.)
    PubMedGoogle Scholar
  • 9 Collen D. Mechanisms of inhibition of tissue-type plasminogen activator in blood. Thromb Haemostas 1983; 50: 678
    PubMedGoogle Scholar
  • 10 Kawano T, Morimoto K, Uemura Y. Urokinase inhibitor in human placenta. Nature 1968; 217: 253-254
    CrossrefPubMedGoogle Scholar
  • 11 Christensen U, Holmberg L, Bladh BAstedt. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue. Thromb Haemostas 1982; 48: 24-26
    PubMedGoogle Scholar